Free Trial

LogicMark (LGMK) Competitors

LogicMark logo
$0.26 0.00 (-0.66%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.26 +0.00 (+0.70%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LGMK vs. NUWE, TIVC, CTCX, CHEK, TNON, SINT, HSCS, AMIX, NDRA, and GMVDF

Should you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include Nuwellis (NUWE), Tivic Health Systems (TIVC), Carmell (CTCX), Check-Cap (CHEK), Tenon Medical (TNON), Sintx Technologies (SINT), Heart Test Laboratories (HSCS), Autonomix Medical (AMIX), ENDRA Life Sciences (NDRA), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry.

LogicMark vs.

LogicMark (NASDAQ:LGMK) and Nuwellis (NASDAQ:NUWE) are both small-cap industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

7.9% of LogicMark shares are held by institutional investors. Comparatively, 3.1% of Nuwellis shares are held by institutional investors. 3.5% of LogicMark shares are held by insiders. Comparatively, 2.6% of Nuwellis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

LogicMark has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.31, suggesting that its share price is 69% less volatile than the S&P 500.

LogicMark has a net margin of -141.96% compared to Nuwellis' net margin of -169.54%. LogicMark's return on equity of -124.91% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
LogicMark-141.96% -124.91% -92.05%
Nuwellis -169.54%-28,159.25%-207.24%

LogicMark has higher revenue and earnings than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LogicMark$9.93M0.07-$14.55M-$223.500.00
Nuwellis$8.86M0.64-$20.21M-$116.41-0.01

Nuwellis has a consensus target price of $17.00, suggesting a potential upside of 1,207.69%. Given Nuwellis' stronger consensus rating and higher probable upside, analysts plainly believe Nuwellis is more favorable than LogicMark.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LogicMark
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nuwellis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Nuwellis received 22 more outperform votes than LogicMark when rated by MarketBeat users.

CompanyUnderperformOutperform
LogicMarkN/AN/A
NuwellisOutperform Votes
22
53.66%
Underperform Votes
19
46.34%

In the previous week, LogicMark and LogicMark both had 3 articles in the media. LogicMark's average media sentiment score of 0.50 beat Nuwellis' score of -0.34 indicating that LogicMark is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LogicMark
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nuwellis
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

LogicMark beats Nuwellis on 10 of the 17 factors compared between the two stocks.

Get LogicMark News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LGMK vs. The Competition

MetricLogicMarkSurgical appliances & supplies IndustryIndustrial SectorNASDAQ Exchange
Market Cap$710,000.00$10.39B$9.17B$9.14B
Dividend YieldN/A1.39%2.10%3.86%
P/E Ratio0.0018.8716.9119.19
Price / Sales0.0745.664.3370.88
Price / CashN/A19.7022.0934.83
Price / Book0.005.394.414.62
Net Income-$14.55M$284.66M$424.79M$246.06M
7 Day Performance-56.31%-4.34%-2.87%-2.63%
1 Month Performance-80.06%-4.85%-5.50%-2.15%
1 Year Performance-98.95%-13.80%29.45%12.88%

LogicMark Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGMK
LogicMark
1.0406 of 5 stars
$0.26
-0.7%
N/A-99.0%$710,000.00$9.93M0.0020High Trading Volume
NUWE
Nuwellis
2.056 of 5 stars
$1.29
-0.8%
$17.00
+1,217.8%
-94.0%$5.64M$8.97M-0.0170News Coverage
Gap Down
TIVC
Tivic Health Systems
0.5739 of 5 stars
$0.57
-24.2%
N/A-62.3%$5.41M$957,000.000.0010Gap Down
High Trading Volume
CTCX
Carmell
N/A$0.25
+2.5%
N/A-92.2%$5.14MN/A0.0014
CHEK
Check-Cap
0.4446 of 5 stars
$0.86
-4.3%
N/A-68.1%$5.04MN/A-0.2980Analyst Forecast
TNON
Tenon Medical
1.6827 of 5 stars
$1.46
flat
$5.50
+276.7%
+23.0%$4.58M$3.32M-0.058
SINT
Sintx Technologies
0.9952 of 5 stars
$2.95
-0.7%
N/A-82.2%$3.95M$2.63M-0.0640News Coverage
Gap Down
HSCS
Heart Test Laboratories
2.4729 of 5 stars
$3.91
+2.6%
$13.50
+245.3%
-69.2%$3.83M$20,000.00-0.4910
AMIX
Autonomix Medical
1.8523 of 5 stars
$2.84
-0.4%
$28.00
+885.9%
-96.2%$3.27MN/A-0.181News Coverage
NDRA
ENDRA Life Sciences
2.3514 of 5 stars
$5.02
+0.1%
$700,000.00
+13,958,025.6%
-100.0%$2.71MN/A-0.0120
GMVDF
G Medical Innovations
N/AN/AN/A-99.3%$2.60M$4.42M0.0072

Related Companies and Tools


This page (NASDAQ:LGMK) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners